May 31, 2006 3:00 a.m. EST
Yvonne Lee - All Headline News Staff Reporter
Washington, D.C. (AHN) - A new study suggests Risperdal may be linked to 70 percent of pituitary tumors.
The Food and Drug Administration worked in conjunction with Duke University on the study, which found the antipsychotic and similar medications may cause pituitary tumors.
The researchers caution the study's findings suggest, rather than prove, a link.
Healthday News reports Risperdal is the most commonly-prescribed medication among atypical antipsychotics. These are used to treat schizophrenia, paranoia, and manic-depressive disorders.
Study co-author Dr. P. Murali Doraiswamy, a psychiatrist at Duke University Medical Center, says, "Atypical antipsychotics are lifesaving medications for a lot of people. By no means are we advocating that people stop using them, especially risperidone."
The findings appear in the June 2 issue of Pharmacotherapy.
http://www.allheadlinenews.com/articles/7003760576